These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 26938532)
1. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries. Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. Yang YL; Wang FS; Li SC; Tiao MM; Huang YH Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784 [TBL] [Abstract][Full Text] [Related]
3. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4. Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. Huang YH; Kuo HC; Yang YL; Wang FS Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice. Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510 [TBL] [Abstract][Full Text] [Related]
6. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha. Yang YL; Wang FS; Lin HY; Huang YH Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice. Lin YC; Wang FS; Yang YL; Chuang YT; Huang YH Biochem Biophys Res Commun; 2018 Feb; 496(3):880-886. PubMed ID: 29366780 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Tiao MM; Wang FS; Huang LT; Chuang JH; Kuo HC; Yang YL; Huang YH Apoptosis; 2014 Jan; 19(1):30-41. PubMed ID: 24052410 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of miR-29a on diabetic glomerular dysfunction by modulation of DKK1/Wnt/β-catenin signaling. Hsu YC; Chang PJ; Ho C; Huang YT; Shih YH; Wang CJ; Lin CL Sci Rep; 2016 Jul; 6():30575. PubMed ID: 27460630 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway. Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis. Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809 [TBL] [Abstract][Full Text] [Related]
13. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway. Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428 [TBL] [Abstract][Full Text] [Related]
14. Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical Carcinogenesis. Zhou L; Pradhan-Sundd T; Poddar M; Singh S; Kikuchi A; Stolz DB; Shou W; Li Z; Nejak-Bowen KN; Monga SP Am J Pathol; 2015 Dec; 185(12):3274-89. PubMed ID: 26485505 [TBL] [Abstract][Full Text] [Related]
15. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis. Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872 [TBL] [Abstract][Full Text] [Related]
16. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Uchinami H; Seki E; Brenner DA; D'Armiento J Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway. Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031 [TBL] [Abstract][Full Text] [Related]
18. The Role of miR-29a in the Regulation, Function, and Signaling of Liver Fibrosis. Huang YH; Yang YL; Wang FS Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954104 [TBL] [Abstract][Full Text] [Related]
19. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling. Li D; Ye C; Liu P; Sun T; Qin Y; Wan X Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066 [TBL] [Abstract][Full Text] [Related]
20. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Roderburg C; Urban GW; Bettermann K; Vucur M; Zimmermann H; Schmidt S; Janssen J; Koppe C; Knolle P; Castoldi M; Tacke F; Trautwein C; Luedde T Hepatology; 2011 Jan; 53(1):209-18. PubMed ID: 20890893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]